Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplivanserin vs Lormetazepam in Insomnia
NCT00679900Phase 3Completed
- Sponsor
- Sanofi
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of eplivanserin in Insomnia, sponsored by Sanofi. Started Apr 2008; status: completed.
02
Drugs
eplivanserin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00679900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679900.